Precision ADM Inc reported on Thursday the receipt of the ISO 13485:2016 Quality Management System certification for its first Canadian metal Additive and Subtractive manufacturing services company.
This ISO 13485:2016 industry standard reportedly represents the comprehensive set of requirements for the design and manufacture of medical devices.
Achieving ISO 13485 Registration and Certification allows the company to manufacture medical devices, including Orthopaedic Implants, using the latest digital manufacturing technologies that can lower production costs by reducing waste and decreasing time to market by simplifying - or eliminating - tooling and equipment.
The Additive Manufacturing makes it possible to produce custom, patient-specific designs and devices with complex geometries, with potential lower cost than traditional manufacturing methods. The company is currently targeting additively manufactured medical devices produced in Titanium, Cobalt-Chrome and stainless-steel alloys.
Headquartered in Winnipeg, Manitoba, Canada, Precision ADM Inc is an engineering and manufacturing solutions provider that uses Additive Manufacturing, also known as 3D Printing, as a core technology, complimented by multi-axis machining to manufacture high value components and devices for the medical and industrial sectors.
Airiver medical receives FDA approval for central airway stenosis trial
Talphera reaches enrollment milestone in NEPHRO CRRT pivotal trial
QT Imaging signs exclusive USD33m distribution deal with Gulf Medical in Saudi Arabia
Novocure submits FDA PMA for Tumor Treating Fields therapy in pancreatic cancer
Covalon Technologies secures DTC eligibility to expand US investor access
Navamedic ASA secures final approvals for Flexilev in OraFID across Nordic markets
Oncopeptides partners with SD Pharma to expand Pepaxti access in Spain
Aptar launches bio-based nasal spray pump with Haleon's Otrivin brand
PharmaJet signs MOU with Egyptian UPA and EVA Pharma to introduce needle-free vaccine delivery
Alcon to acquire LumiThera and its FDA-authorised photobiomodulation device for dry AMD treatment
Predictmedix AI launches mobile diabetes screening platform in India
Navamedic's medical device OraFID approved as primary package for a pharmaceutical product
Speranza Therapeutics partners with Sunshine Labs for harm reduction solutions